Asposid 75 mg 30 chewable tablets

Tradename

Asposis

Aspocid

Composition

Each chewable tablet contains:

Acetylsalicylic Acid 75mg

Properties

Asposid is a salicylate NSAID that has a bloodthinning effect.

Indications

secondary prevention of myocardial infarction; prevention of cardiovascular morbidity in patients with stable angina pectoris; unstable angina pectoris, except in cases of the acute phase. Phase Secondary prevention of transient ischemic attacks and ischemic cerebrovascular accidents in the absence o intracerebral hemorrhage. The drug is not recommended in emergency situations. It is

limited to secondary prevention of chronic disease.

Mode of application:

Contraindications

Children under 12 years old; hypersensitivity to salicylates and aspirin and other NSAlDs; bleeding tendency; peptic ulcer and 12 duodenal ulcer; severe diseases of the heart,

liver, kidneys; pregnancy and lactation.

Precautions:

Side effects

headache, dizziness, confusion, hearing impairment, tinnitus, indigestion (nausea, heartburn, vomiting, abdominal pain, diarrhea), gastric microbleeding, impaired renal function and acute renal failure.

Storage

Store at a temperature not exceeding 30C, out of reach of children.

Packaging:

The cardboard box contains 5 blisters of 6 tablets each, paper instructions.